Sartorius AG and its biotech subsidiary lifted to Buy at Barclays
Investing.com -- Barclays has upgraded Sartorius AG (F:SATG) and its subsidiary Sartorius Stedim (EPA:STDM) Biotech SA (VIE:DIM) to Overweight, citing a shift in the bioprocessing industry toward a post-COVID recovery.